PRC-063 in an ADULT Workplace Environment
Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
- DRUG: PRC-063 25 mg
- DRUG: Placebo
- DRUG: PRC-063 35 mg
- DRUG: PRC-063 45 mg
- DRUG: PRC-063 55 mg
- DRUG: PRC-063 70 mg
- DRUG: PRC-063 85 mg
- DRUG: PRC-063 100 mg
Sponsor
Rhodes Pharmaceuticals, L.P.
Collaborators